Results 11 to 20 of about 58,832 (240)

New biomarkers for the diagnosis of pleural effusion

The Egyptian Journal of Bronchology, 2022
Background Persistent undiagnosed effusion is present in approximately 15% of all causes of exudative effusion. Pleural effusion caused by immunoglobulin G4 (IgG4) is a new type of pleural effusion.
Raafat T. El-Sokkary, Nermen M. Abuelkassem, Mohamed Ismail Seddik, Ahmed Metwally   +3 more
doaj   +1 more source

Malignant Pleural Effusions: Management Options [PDF]

Seminars in Respiratory and Critical Care Medicine, 2018
AbstractMalignant pleural effusion (MPE) represents advanced metastatic malignancy and is associated with poor median survival. Incidence remains high and continues to rise, in part due to changing population demographics. This therefore represents a significant health care burden.
McCracken, DJ, Porcel, JM, Rahman, NM
openaire   +2 more sources

C-reactive protein and serum amyloid A levels in discriminating malignant from non-malignant pleural effusion

Egyptian Journal of Chest Disease and Tuberculosis, 2015
Introduction: Distinction between malignant and non-malignant pleural effusion is of great importance in the patient management. The aim: We examined the diagnostic value of C-reactive protein (CRP) and serum amyloid A (SAA) in distinguishing different ...
Hala Mohamed Shalaby Samaha, Amany Ragab Elsaid, Rasha Elzehery, Rania Elhelaly   +3 more
doaj   +1 more source

Recurrence of malignant melanoma presenting as black-colored pyopneumothorax: a rare entity

Annals of Saudi Medicine, 2017
We report a 63-year-old patient with black-colored pus (pyopneumothorax) resulting from an infected pleural effusion associated with metastatic malignant melanoma of the skin.
Ganesh Patel, Anil Saxena, Suman Khangarot, Rajendra Prasad Takhar, Dinesh Patel   +4 more
doaj   +1 more source

The role of tumor necrosis factor alpha in differentiation between malignant and non malignant pleural effusion

Egyptian Journal of Chest Disease and Tuberculosis, 2016
Background: Despite the fact that Light’s criteria remain the gold standard approach in differentiating exudates from transudates, several fluid markers have been introduced for establishing the cause of pleural effusion to differentiate types of pleural
Heba M. Atef, Ali A. Okab, Gehan F. Al mehy, Mona M. El Beheisy   +3 more
doaj   +1 more source

Value of Detection of CAIX in the Pleural Effusion and Its Sediment in the Diagnosis of Lung Cancer

Chinese Journal of Lung Cancer, 2015
Background and objective Carbonic anhydrase IX (CAIX) is widely expressed in a variety of malignant tumors, including-lung cancer. Our previous study has shown that the serum level of soluble form of carbonic anhydrase IX (s-CAIX) was significantly ...
Lina PENG, Xiao’e WANG, Diansheng ZHONG, Qian WANG, Chang LIU   +4 more
doaj   +1 more source

Superoxide dismutase 2 as a marker to differentiate tuberculous pleural effusions from malignant pleural effusions

Clinics, 2014
OBJECTIVES: Our previous study demonstrated that superoxide dismutase levels were higher in tuberculous pleural effusions than in malignant pleural effusions, but that this difference ...
Maoshui Wang, Zhiqiang Zhang, Xinfeng Wang   +2 more
doaj   +1 more source

Different Therapeutic Strategies in 2 Young Patients with Advanced ALK-Rearranged Lung Adenocarcinoma: “The Light at the End of the Tunnel”

Case Reports in Oncology, 2021
Malignant pleural effusion represents a prognostic negative factor on survival conferring stage IV disease. The median of survival is 5 months and a 5-year survival of about 3%.
Umberto Caterino, Cristiano Cesaro, Enzo Zamparelli, Flavio Cesaro, Alba Palma, Raffaella Lucci, Pasquale Imitazione, Dino Casazza, Dario Amore   +8 more
doaj   +1 more source

Diagnostic Values of Vascular Endothelial Growth Factor and Epidermal Growth Factor Receptor for Benign and Malignant Hydrothorax

Chinese Medical Journal, 2015
Background: Hydrothorax, as one of the common complications of malignant tumors, still cannot be sensitively detected in clinical practice, thus requiring a sensitive, specific method for diagnosis.
Yan Gu, Min Zhang, Guo-Hua Li, Jun-Zhen Gao, Liping Guo, Xiao-Juan Qiao, Li-Hong Wang, Lan He, Mei-Ling Wang, Li Yan, Xiu-Hua Fu   +10 more
doaj   +1 more source

Reactive oxygen species modulator 1, a novel protein, combined with carcinoembryonic antigen in differentiating malignant from benign pleural effusion

Tumor Biology, 2017
The differential diagnosis of malignant pleural effusion and benign pleural effusion remains a clinical problem. Reactive oxygen species modulator 1 is a novel protein overexpressed in various human tumors. The objective of this study was to evaluate the
Xianmeng Chen, Na Zhang, Jiahui Dong, Gengyun Sun   +3 more
doaj   +1 more source